Management of acute intractable headaches using i.v. therapy in an office setting.
Twenty-seven consecutive patients with acute intractable headaches were treated in an office setting with an intravenous protocol of an antiemetic, hydrocortisone sodium succinate, and dihydroergotamine (DHE). All patients had significant pain relief within 45 minutes. Patients who were not pain-free post-treatment uniformly reported decreasing pain at the time of departure from the office. No patients required further treatment (including narcotic medication) for acute headache. All patients were followed for at least 24 hours. Adverse reactions were transient and mild. Akathisia was not uncommon and has probably been underestimated in previous studies.
Stiller
J
J
D000208:Acute Disease; D000328:Adult; D000553:Ambulatory Care; D000932:Antiemetics / Q000627:therapeutic use*; D004087:Dihydroergotamine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006261:Headache / Q000188:drug therapy*; D006801:Humans; D006854:Hydrocortisone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects
D000932:Antiemetics; D004087:Dihydroergotamine; C007133:hydrocortisone hemisuccinate; D006854:Hydrocortisone